Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Hologic Wins $4.1m To Advance Zika Blood Screen

Executive Summary

The US Biomedical Advanced Research and Development Authority (BARDA) recently granted $4.1m to Hologic to advance development of a blood screen to detect Zika in the blood supply. Also, lawmakers are asking more questions about readiness in the US for detecting emerging infectious diseases and bioterrorism-related toxins.

Advertisement

Related Content

Hologic/Grifols, Roche Molecular Zika Tests Tapped For Blood-Screening Ramp-Up
Chembio Wins $13.2M US BARDA Contract To Develop POC Zika Tests
Feds Closer To Dx Distinguishing Zika From Dengue As HHS Tries To Plug Funding Gap
House-Senate Conferees Fight Over Zika Funds As FDA Approves More Assays

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT103717

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel